120 related articles for article (PubMed ID: 3491675)
1. Enhancement of therapeutic effects of recombinant interleukin 2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, pluronic gel.
Morikawa K; Okada F; Hosokawa M; Kobayashi H
Cancer Res; 1987 Jan; 47(1):37-41. PubMed ID: 3491675
[TBL] [Abstract][Full Text] [Related]
2. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Sugawara M; Kobayashi H
Cancer Res; 1985 Apr; 45(4):1502-6. PubMed ID: 2579730
[TBL] [Abstract][Full Text] [Related]
3. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Xu ZY; Kobayashi H
Cancer Res; 1986 Feb; 46(2):684-8. PubMed ID: 2416431
[TBL] [Abstract][Full Text] [Related]
4. Host immune responses to tumor cells augmented by bleomycin and their therapeutic effects on rat fibrosarcoma.
Hosokawa M; Xu ZY; Morikawa K; Hamada J; Kobayashi H
Mol Biother; 1988; 1(2):74-80. PubMed ID: 2479397
[TBL] [Abstract][Full Text] [Related]
5. [Enhancement of antitumor immune responses by bleomycin].
Morikawa K
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):772-80. PubMed ID: 2467868
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery.
Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M
Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
[TBL] [Abstract][Full Text] [Related]
8. ReGel polymer-based delivery of interleukin-2 as a cancer treatment.
Samlowski WE; McGregor JR; Jurek M; Baudys M; Zentner GM; Fowers KD
J Immunother; 2006; 29(5):524-35. PubMed ID: 16971808
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of IL-2 entrapped in liposomes on rat hepatoma, AH-66].
Konno H; Toriyama H; Aoki K; Baba S; Sakaguchi S; Yamashita A; Tadakuma T
Gan To Kagaku Ryoho; 1989 Jan; 16(1):53-8. PubMed ID: 2783545
[TBL] [Abstract][Full Text] [Related]
10. Generation of lymphokine-activated killer cells in strain 2 guinea pigs and their use in the therapy of L2C, an acute B-cell leukemia.
Gregg EO; Gregg IC; Green I
Cancer Res; 1987 Feb; 47(3):723-9. PubMed ID: 3492265
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of T cell-mediated immune responses in KMT-17-bearing rats by treatment with bleomycin].
Xu ZY
Hokkaido Igaku Zasshi; 1987 Mar; 62(2):279-88. PubMed ID: 2440789
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.
Mizushima Y; Sendo F; Takeichi N; Hosohawa M; Kobayashi H
Cancer Res; 1981 Jul; 41(7):2917-21. PubMed ID: 6454480
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
[TBL] [Abstract][Full Text] [Related]
14. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
15. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin.
Xu ZY; Hosokawa M; Morikawa K; Hatakeyama M; Kobayashi H
Cancer Res; 1988 Dec; 48(23):6658-63. PubMed ID: 2460226
[TBL] [Abstract][Full Text] [Related]
16. The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.
Donohue JH; Rosenstein M; Chang AE; Lotze MT; Robb RJ; Rosenberg SA
J Immunol; 1984 Apr; 132(4):2123-8. PubMed ID: 6607956
[TBL] [Abstract][Full Text] [Related]
17. Adoptive immunotherapy of a Gross virus producing lymphoma and a methylcholanthrene-induced fibrosarcoma in tolerant rats.
Takeichi N; Kuzumaki N; Kodama T; Kobayashi H; Boone CW
Cancer Res; 1976 Nov; 36(11 Pt 1):4039-43. PubMed ID: 10076
[TBL] [Abstract][Full Text] [Related]
18. Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1.
Izumi Y; Tsuchida T; Okuno K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Sep; 76(9):863-70. PubMed ID: 3932286
[TBL] [Abstract][Full Text] [Related]
19. The antitumor effect induced by local injections with interleukin-2 is diminished by combing with a local injection with mitomycin C.
Li T; Harada M; Tamada K; Abe K; Ito O; Takenoyama M; Nomoto K
Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):497-509. PubMed ID: 8933166
[TBL] [Abstract][Full Text] [Related]
20. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
